Results 51 to 60 of about 4,975 (118)

Reducing morbidity and mortality in high risk patients with statins

Vascular Health and Risk Management, 2009
Vibhuti Singh1, Prakash Deedwania21University of South Florida College of Medicine, and Suncoast Cardiovascular Center, St. Petersburg, Florida, USA; 2Cardiology Division, VACCHCS/UCSF, Fresno, CA, and UCSF School of Medicine, San Francisco, CA ...
Vibhuti Singh, Prakash Deedwania
doaj  

Multimodal Imaging Investigation of the Dentato‐Thalamo‐Cortical Pathway in Friedreich's Ataxia

Movement Disorders, Volume 41, Issue 4, Page 909-920, April 2026.
Abstract Background Friedreich's ataxia (FRDA) is a spinocerebellar neurodegenerative disorder. The dentato‐thalamo‐cortical (DTC) pathway, an important cerebellar output involved in motor control, plays a crucial role in the neural mechanisms underlying ataxia symptoms in FRDA.
Yinghua Jing, Imis Dogan, Ravi Dadsena, Jennifer Faber, Jörg B. Schulz, Kathrin Reetz, Sandro Romanzetti, on behalf of the FACROSS study group, Stella A. Lischewski, Kerstin Konrad, Miguel Pishnamaz, Maximillian Praster, Thomas Clavel, Vera Jankowski, Joachim Jankowski, Oliver Pabst, Katharina Marx‐Schütt, Nikolaus Marx, Julia Möllmann, Malte Jacobsen, Juergen Dukart, Simon Eickhoff, Ralf‐Dieter Hilgers   +22 more
wiley   +1 more source

The words community dwelling, Spanish‐preferring Mexican/Mexican American adults use to talk about Alzheimer's disease and genetic testing: Implications for education and outreach

Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 2, April/June 2026.
Abstract INTRODUCTION Hispanic/Latino (H/L) adults are more likely than non‐Hispanic White individuals to have Alzheimer's disease (AD), yet fewer than one in five H/L adults has apolipoprotein E (APOE) Ɛ4, underscoring gaps in understanding genetic risk across H/L heritage groups.
Jamie C. Fong, Fatima I. Chavez, Karla Silos, Mirna L. Arroyo‐Miranda, Gabriela Castro Castro, Mark E. Kunik, Joshua M. Shulman, Luis D. Medina   +7 more
wiley   +1 more source

The landscape of dementia research, diagnosis, treatment, and care in Latin America

Alzheimer's &Dementia, Volume 22, Issue 3, March 2026.
Abstract Latin America is undergoing rapid population aging alongside a rising burden of dementia. While the region holds substantial potential for dementia risk reduction, challenges remain, such as delayed diagnoses, limited access to specialized care and biomarker testing, persistent stigma, and deep‐rooted structural inequities.
Claudia K. Suemoto, Nilton Custodio, Diego Aguilar, José A. Avila‐Funes, Sandra Baez, Pablo M. Bagnati, Lisa L. Barnes, Sonia M. D. Brucki, Ismael L. Calandri, Paulo Caramelli, Mario Cornejo‐Olivas, Carolina Delgado Derio, Sergio T. Ferreira, Adolfo M. García, Lea T. Grinberg, Agustin M. Ibanez, Rosario Isasi, Sylvia E. Josephy‐Hernández, Maria Lazo Porras, Jorge J. Llibre‐Guerra, Juan J. Llibre‐Rodriguez, Mychael V. Lourenco, B. Marcela Mar Meza, Joaquin Migeot, J. Jaime Miranda, Claudia Miranda‐Castillo, Catherine J. Mummery, José F. Parodi, Natalia Pozo Castro, Rosa María Salinas Contreras, Hernando Santamaría‐García, Andrea Slachevsky, Juliana N. Souza‐Talarico, Ezequiel I. Surace, Leonel T. Takada, Elena Tsoy, Martha Unaucho Pilalumbo, Eduardo R. Zimmer, Igor C Fontana, Simin Mahinrad, Heather M. Snyder, Maria C. Carrillo   +41 more
wiley   +1 more source

Aterosclerosis y afectación de la función cognitiva Atherosclerosis and cognitive function impairment

Revista Cubana de Investigaciones Biomédicas, 2012
La aterosclerosis es un proceso de origen multicausal y se acompaña de una gran variedad de manifestaciones clínicas y humorales. Son conocidos los factores de riesgo aterogénicos como dislipidemias, hipertensión arterial, diabetes mellitus, obesidad ...
Regino Piñeiro Lamas, José Emilio Fernández-Britto Rodríguez, Ivo Gómez Padrón   +2 more
doaj  

Preventive cytoprotection in social diseases

Терапевтический архив, 2015
Among many cytoprotective drugs, only a few of them that have a targeted metabolic effect include agents that partially inhibit oxidation of free fatty acids, the so-called p-FOX inhibitors (partial fatty acid oxidation inhibitors). Aim.
A S Skotnikov, G N Gorokhovskaya, A M Shilov, V L Yun, M A Khamurzova   +4 more
doaj  

Cirrosis y encefalopatía hepáticas: consecuencias clínico-metabólicas y soporte nutricional Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support

Nutrición Hospitalaria, 2008
La cirrosis representa el estadio final de muchas enfermedades crónicas del hígado y se asocia con malnutrición en mayor o menor grado, con independencia de su etiología, sobre todo en los estadios avanzados.
A. Mesejo, M. Juan, A. Serrano
doaj  

Marcadores inflamatórios e anticorpos anti-chlamydia em pacientes com síndrome metabólica Marcadores inflamatorios y anticuerpos anti-chlamydia en pacientes con síndrome metabólico Inflammatory markers and antichlamydial antibodies in patients with metabolic syndrome

Arquivos Brasileiros de Cardiologia, 2011
FUNDAMENTO: A síndrome metabólica está associada ao aumento de risco de eventos cardiovasculares. Marcadores inflamatórios e anticorpos anti-Chlamydia têm sido relacionados ao desenvolvimento e à progressão da aterosclerose e dos eventos cardiovasculares.
Rosecler Riethmuller Franco, Luiz Carlos Bodanese, Giuseppe Repetto, Jacqueline da Costa Escobar Piccoli, Mario Wiehe, Cassiane Bonato, Marta Maria Medeiros Frescura Duarte, Thiago Duarte   +7 more
doaj  

ePoster

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source